Immuron Ltd
IMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660046
No open-market purchases or sales by Immuron Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $82.2K in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Immuron Ltd changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 6 | 4 | −2 |
| Shares | 92.8K | 11.8K | −81.0K (−87.3%) |
| Value | $171.5K | $23.8K | −$147.7K (−86.1%) |
New holders (2)
Institutions that held Immuron Ltd at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BNP Paribas Arbitrage, SA | 3,346 | $6.76K | 0.00% |
| Global Wealth Management Investment Advisory, Inc. | 100 | $202 | 0.00% |
Sold out (4)
Institutions that held Immuron Ltd at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 39,404 | $72.5K |
| Citadel Advisors LLC | 31,252 | $57.5K |
| Old Mission Capital LLC | 15,537 | $29.1K |
| UBS Group AG | 197 | $369 |